Authors Boyer, Medicis, Pappas, Potenziano, Jamil K
Received 18 July 2012
Accepted for publication 18 July 2012
Published 13 August 2012 Volume 2012:4 Pages 59—60
Boyer TD, Medicis JJ, Pappas SC, Potenziano J, Jamil K. A randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design. Open Access Journal of Clinical Trials. 2012;4:39–49.
Dr Jamil’s first name was incorrectly spelt as Khuramm Jamil in the author list. The correct spelling is Khurram Jamil.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]